MENU
SNGX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Soligenix (SNGX) Ownership - Who owns Soligenix?
Soligenix Inc is a late-stage biopharmaceutical company based in the United States... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
29 Emmons Drive
Phone
+1 609 538-8200
Employees
15
Web
https://www.soligenix.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
6.52M
P/E Ratio
N/A
Total Cash
9.84M
Projected Growth
N/A
Total Debt
2.2M
Revenue
N/A
Risk (Beta)
2.67
Dividend Yield
N/A
Total Cash/Share
3.12
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
SNGX
Capitalization
6.52M
P/E Ratio
N/A
Risk (Beta)
2.67
Dividend Yield
N/A
Total Cash
9.84M
Total Cash/Share
3.12
Total Debt
2.2M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
5.94M
P/B Ratio
1.59
Cash Flow
N/A
Earnings
-6.43
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2.3K
Current Ratio
2.28
Current Revenue Per Employee
7801.93
Dividends Per Share - Security
N/A
EBITDA
-8.06M
Float
N/A
Float - Current
N/A
Gross Income Margin
0.00
Revenue To Assets
-65.19
Shares Held By Institutions
151K
Shares Outstanding - Current
3.16M
Total Liabilities
4.54M
Total Volume MTD
N/A
Value
1
Gain YTD
-23.191
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a manufacturer of biodefense vaccines and oral therapeutic products
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
29 Emmons Drive
Phone
+1 609 538-8200
Employees
15
Web
https://www.soligenix.com